KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Goodwill & Intangibles (2016 - 2025)

Historic Goodwill & Intangibles for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to $2.9 billion.

  • Edwards Lifesciences' Goodwill & Intangibles rose 1319.2% to $2.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 billion, marking a year-over-year increase of 1319.2%. This contributed to the annual value of $3.0 billion for FY2024, which is 9121.4% up from last year.
  • Per Edwards Lifesciences' latest filing, its Goodwill & Intangibles stood at $2.9 billion for Q3 2025, which was up 1319.2% from $2.9 billion recorded in Q2 2025.
  • Over the past 5 years, Edwards Lifesciences' Goodwill & Intangibles peaked at $3.0 billion during Q1 2025, and registered a low of $1.4 billion during Q4 2022.
  • Its 5-year average for Goodwill & Intangibles is $1.9 billion, with a median of $1.6 billion in 2024.
  • In the last 5 years, Edwards Lifesciences' Goodwill & Intangibles tumbled by 948.71% in 2022 and then skyrocketed by 9121.4% in 2024.
  • Edwards Lifesciences' Goodwill & Intangibles (Quarter) stood at $1.5 billion in 2021, then decreased by 9.49% to $1.4 billion in 2022, then rose by 14.41% to $1.5 billion in 2023, then skyrocketed by 91.21% to $3.0 billion in 2024, then decreased by 1.83% to $2.9 billion in 2025.
  • Its last three reported values are $2.9 billion in Q3 2025, $2.9 billion for Q2 2025, and $3.0 billion during Q1 2025.